BillionToOne, Inc.
NASDAQ:BLLNMedical - Diagnostics & Research
+$0.84 today
- Market cap
- $4.37B
- Beta
- 0.90
- P/E (TTM)
- 182.6
- EPS (TTM)
- $0.55
Volume 1.44M
Average 0.59M
BLLN Total Non-current Assets
All assets not expected to be converted to cash within one year.
BillionToOne, Inc.NASDAQ: BLLN
Total Non-current Assets · Q2 FY2026 · quarter ended Jun 2026
Total non-current assets rises 2.4% from a year ago
Total non-current assets stood at $78.32M at the end of Q2 FY2026, up 2.4% from a year earlier and up 2.3% from the prior quarter.
Context
- Total non-current assets amounted to 10.7% of total assets at the end of Q2 FY2026, down 13.7 pp from a year earlier.
- Total non-current assets increased in 0 of the last 2 fiscal years.
- FY2025 was the lowest annual figure in the 3 fiscal years shown.
What to watch
Whether total non-current assets keeps rising in the next quarterly balance sheet after a +2.4% change from a year earlier.
Sources:Balance SheetText generated from reported figures; not investment advice.
Total Non-current Assets history
USD · from the balance sheet
- Latest · FY2025
- 72.1M USD
- Year-over-year change
- -2.9%
- 2-year CAGR
- -2.7%
| Period | Period end | Total Non-current Assets | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 72.1M | -2.9% |
| FY2024 | 2024-12-31 | 74.24M | -2.5% |
| FY2023 | 2023-12-31 | 76.18M | — |
Total Non-current Assets vs competitors
How BLLN compares with its peers on the latest reported figures
- BLLN's Jun 2026 total non-current assets of $78.32M is the lowest of the 9 companies compared; the peer median is $794.46M.
- Its year-over-year change of +2.4% is the 3rd highest of 9, against a peer median of -4.5%.
- Total non-current assets amounts to 10.7% of total assets for BLLN, versus a peer median of 56.1%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Jun 2026 | $1.93B | -5.9% | -28.2% | 67.8% | |
| Jun 2026 | $998.55M | +206.8% | +76.9% | 37.6% | |
| Jun 2026 | $970.77M | -3.1% | -4.7% | 71.8% | |
| Jun 2026 | $911.59M | -1.9% | +0.4% | 61.3% | |
| Mar 2026 | $677.33M | -14.1% | -4.4% | 58.6% | |
| Sep 2026 | $542.24M | +21.1% | +9.4% | 28.8% | |
| Mar 2026 | $360.9M | -49.8% | -26.0% | 53.6% | |
WGSGeneDx Holdings Corp. | Jun 2026 | $235.13M | -9.2% | -3.2% | 48.8% |
BLLNBillionToOne, Inc. | Jun 2026 | $78.32M | +2.4% | — | 10.7% |
| Peer median (excluding BLLN) | $794.46M | -4.5% | -3.8% | 56.1% | |
Competitors are the stored peer set for BLLN. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
BillionToOne, Inc.
NASDAQ:BLLN
Intrinsic Alpha fair value
Locked
Current Price
$91.54
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.